MVP winner eyes UFC contract after first-round finish
Salahdine Parnasse is already targeting bigger opportunities after an impressive debut for Most Valuable Promotions. The lightweight fighter defeated Kenneth Cross in dominant fashion at MVP's "Rousey vs. Carano" card Saturday in Los Angeles, securing a first-round finish and catching the attention of major promotional decision-makers.
Parnasse's performance has prompted his management to pursue a UFC contract. His manager, Stephane Chaufourier, took to Instagram to express interest in the opportunity, tagging UFC president Dana White and the organization directly. The message—"We've done our part. The ball is in your court"—signals confidence that the win was impressive enough to merit serious consideration from the sport's largest promotion.
At just 28 years old, Parnasse brings significant regional experience to the conversation. The fighter is a former KSW two-division champion with an impressive finishing rate: 15 of his 23 professional victories have come by knockout or submission, while he has suffered only two losses. This record demonstrates both consistency and striking power, qualities the UFC actively targets when scouting talent from smaller promotions. Parnasse's case exemplifies a common pattern in modern MMA, where fighters use regional and international showcases as auditions for UFC contracts. A strong performance on a high-profile platform like MVP's debut can accelerate a fighter's timeline toward the world's leading organization, making the visibility of such opportunities invaluable for emerging talent seeking to climb the sport's hierarchy.
More news
All news →- News
Derrick Lewis levels fan with stiff body shot
- News
Cain Velasquez addresses potential comeback after Rousey vs. Carano appearance: ‘The money has to make me want to do it’
- News
Morning Report | Chael Sonnen: Nassourdine Imavov ‘hasn’t demanded’ title shot, leaving door open for Khamzat Chimaev
- News
19-fight UFC veteran announces release following 3rd straight loss
Comments · 0
Sign in to join the conversation.
No comments yet — be the first to weigh in.